Fennec Pharmaceuticals (FENC) Total Debt Growth (1y) (2011 - 2022)
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Total Debt Growth (1y) (2011 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.10% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 12.42% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 3.78% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 257.14% |
| Sep 30, 2022 | 1,150.00% |
| Jun 30, 2022 | 150.00% |
| Dec 31, 2017 | 505,960.61% |
| Sep 30, 2017 | 908.11% |
| Jun 30, 2017 | 239.29% |
| Mar 31, 2017 | 82.05% |
| Dec 31, 2016 | -59.76% |
| Sep 30, 2016 | -60.22% |
| Jun 30, 2016 | -81.88% |
| Mar 31, 2016 | -94.38% |
| Dec 31, 2015 | -93.78% |
| Sep 30, 2015 | -97.34% |
| Jun 30, 2015 | -94.21% |
| Mar 31, 2015 | -87.42% |
| Dec 31, 2014 | -53.93% |
| Sep 30, 2014 | -20.24% |
| Jun 30, 2014 | 99.25% |
| Mar 31, 2014 | -45.97% |
| Dec 31, 2013 | -56.88% |